313 related articles for article (PubMed ID: 37318594)
1. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Feng L; Li G; Li D; Duan G; Liu J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
[TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
3. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
Ma Z; Xu J; Ru L; Zhu W
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of cuproptosis-related immune biomarker signature to enhance prognostic accuracy in gastric cancer.
Li J; Yu T; Sun J; Zeng Z; Liu Z; Ma M; Zheng Z; He Y; Kang W
Aging (Albany NY); 2023 Apr; 15(7):2772-2796. PubMed ID: 37036489
[TBL] [Abstract][Full Text] [Related]
5. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
[TBL] [Abstract][Full Text] [Related]
6. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
Li Y; Kan X
Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
[TBL] [Abstract][Full Text] [Related]
7. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
[TBL] [Abstract][Full Text] [Related]
9. A Novel Cuproptosis-Related Prognostic Model and the Hub Gene
Zhang K; Yang W; Zhang Z; Ma K; Li L; Xu Y; Qiu J; Yu C; Zhou J; Cai L; Gong Y; Gong K
J Oncol; 2022; 2022():2124088. PubMed ID: 36536785
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
Front Genet; 2022; 13():939956. PubMed ID: 36105090
[No Abstract] [Full Text] [Related]
11. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
13. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
14. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma.
Chen Y; Zou X; Ma M; Liu Y; Wang R; Dai Z; Tashiheng Y; Yan Y; Yu X; Wang X; Liu C; Lin X; Cheng H
Curr Oncol; 2023 Jan; 30(2):1648-1662. PubMed ID: 36826087
[TBL] [Abstract][Full Text] [Related]
15. Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature.
Zhou J; Chen D; Zhang S; Wang C; Zhang L
Front Genet; 2022; 13():1039983. PubMed ID: 36712848
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and potential application of cuproptosis-related genes in gastric cancer.
Yan JN; Guo LH; Zhu DP; Ye GL; Shao YF; Zhou HX
World J Gastrointest Oncol; 2023 Jul; 15(7):1200-1214. PubMed ID: 37546553
[TBL] [Abstract][Full Text] [Related]
17. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
Yan C; Niu Y; Ma L; Tian L; Ma J
J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration.
Yao Y; Chen H; Lou M; Chen T
Front Genet; 2023; 14():1071694. PubMed ID: 36755576
[No Abstract] [Full Text] [Related]
20. Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease.
Yuan Y; Fu M; Li N; Ye M
Front Immunol; 2022; 13():1074271. PubMed ID: 36466876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
